KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Cash from Operations (2016 - 2025)

Rigel Pharmaceuticals has reported Cash from Operations over the past 16 years, most recently at 21980000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 51.55% year-over-year to 21980000.0; the TTM value through Dec 2025 reached 75655000.0, up 140.4%, while the annual FY2025 figure was 75655000.0, 140.4% up from the prior year.
  • Cash from Operations for Q4 2025 was 21980000.0 at Rigel Pharmaceuticals, down from 24031000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 55216000.0 in Q2 2021 and troughed at 25637000.0 in Q1 2022.
  • A 5-year average of 1675150.0 and a median of 2716500.0 in 2023 define the central range for Cash from Operations.
  • Biggest five-year swings in Cash from Operations: plummeted 545.17% in 2021 and later soared 10011.59% in 2025.
  • Year by year, Cash from Operations stood at 19086000.0 in 2021, then fell by 14.79% to 21909000.0 in 2022, then skyrocketed by 71.52% to 6240000.0 in 2023, then surged by 332.42% to 14503000.0 in 2024, then soared by 51.55% to 21980000.0 in 2025.
  • Business Quant data shows Cash from Operations for RIGL at 21980000.0 in Q4 2025, 24031000.0 in Q3 2025, and 30537000.0 in Q2 2025.